FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Aakanksha Khandelwal

Research Profile

Chemicals & Drugs

Disorders

Physiology

Down-Regulation

Anatomy

Tumor Cell Line

Concepts & Ideas

Drug Dose Response Relationship

Living Beings

Mouse

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Tadas S Vasaitis; Aashvini Belosay; Adam Schayowitz; Aakanksha Khandelwal; Pankaj Chopra; Lalji Gediya; Zhiyong Guo; Hongbin Fang; Vincent Njar; Angela Brodie
Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.
Jyoti B Patel; Aakanksha Khandelwal; Pankaj Chopra; Venkatesh D Handratta; Vincent Njar
Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.
Puranik Purushottamachar; Aakanksha Khandelwal; Pankaj Chopra; Neha Maheshwari; Lalji Gediya; Tadas S Vasaitis; Robert D Bruno; Omoshile O Clement; Vincent Njar
First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Aakanksha Khandelwal (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2008: Tadas S Vasaitis; Aashvini Belosay; Adam Schayowitz; Aakanksha Khandelwal; Pankaj Chopra; Lalji Gediya; Zhiyong Guo; Hongbin Fang; Vincent Njar; Angela Brodie
Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.
Molecular cancer therapeutics 2008;7(8):2348-57.
2007: Jyoti B Patel; Aakanksha Khandelwal; Pankaj Chopra; Venkatesh D Handratta; Vincent Njar
Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.
Cancer chemotherapy and pharmacology 2007;60(6):899-905.
2007: Puranik Purushottamachar; Aakanksha Khandelwal; Pankaj Chopra; Neha Maheshwari; Lalji Gediya; Tadas S Vasaitis; Robert D Bruno; Omoshile O Clement; Vincent Njar
First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.
Bioorganic & medicinal chemistry 2007;15(10):3413-21.
2007: Jyoti B Patel; J Mehta; Aashvini Belosay; Gauri Sabnis; Aakanksha Khandelwal; Angela Brodie; Dianne Robert Soprano; Vincent Njar
Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
British journal of cancer 2007;96(8):1204-15.
2006: Vincent Njar; Lalji Gediya; Puranik Purushottamachar; Pankaj Chopra; Tadas S Vasaitis; Aakanksha Khandelwal; Jhalak Mehta; Carlic K Huynh; Aashvini Belosay; Jyoti B Patel
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
Bioorganic & medicinal chemistry 2006;14(13):4323-40.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.